The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Monogenetic Disorders Testing Market Research Report 2025
Synopsis
According to Mendel's Laws, the monogenetic disorders are inherited because of a single defective gene on the autosomes. The monogenic disorders are caused by single mutated gene which can be present on single or both chromosomes. Females and males are equally affected by this disorder due to the conditions on the autosomes. Some of the tests are available for the mainstream of the common monogenic disorders such as Cystic fibrosis, sickle cell anemia, SCID, Tay-sachs disease, polycystic kidney disorder, Gaucher's disease, Huntington's disease, neurofibromatosis, thalassaemia and familial hypercholesterolemia. There are several test performed to treat with the monogenic disorders such as diagnostic testing, carrier testing, predictive & pre-symptomatic testing, prenatal testing and new-born screening.
The global Monogenetic Disorders Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North America clearly dominates the global monogenetic disorders testing market due to high degree of intelligence and awareness regarding to the monogenic disorders testing procedures. The companies are focused on introducing the procedures with innovative technology, Europe is expected to hold the second large market followed by Asia-Pacific region.
This report aims to provide a comprehensive presentation of the global market for Monogenetic Disorders Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monogenetic Disorders Testing.
Report Scope
The Monogenetic Disorders Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Monogenetic Disorders Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Monogenetic Disorders Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Celera Group
Abbott
Thermo Fisher Scientific
ELITech Group
Quest
AutoGenomics
PerkinElmer
Roche
Bio-Rad
Transgenomic
Segment by Type
Carrier Testing
Diagnostic Testing
New-Born Screening
Predictive & Pre-Symptomatic Testing
Prenatal Testing
Others
Segment by Application
Hospitals
Specialized Clinics
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Monogenetic Disorders Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
According to Mendel's Laws, the monogenetic disorders are inherited because of a single defective gene on the autosomes. The monogenic disorders are caused by single mutated gene which can be present on single or both chromosomes. Females and males are equally affected by this disorder due to the conditions on the autosomes. Some of the tests are available for the mainstream of the common monogenic disorders such as Cystic fibrosis, sickle cell anemia, SCID, Tay-sachs disease, polycystic kidney disorder, Gaucher's disease, Huntington's disease, neurofibromatosis, thalassaemia and familial hypercholesterolemia. There are several test performed to treat with the monogenic disorders such as diagnostic testing, carrier testing, predictive & pre-symptomatic testing, prenatal testing and new-born screening.
The global Monogenetic Disorders Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North America clearly dominates the global monogenetic disorders testing market due to high degree of intelligence and awareness regarding to the monogenic disorders testing procedures. The companies are focused on introducing the procedures with innovative technology, Europe is expected to hold the second large market followed by Asia-Pacific region.
This report aims to provide a comprehensive presentation of the global market for Monogenetic Disorders Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monogenetic Disorders Testing.
Report Scope
The Monogenetic Disorders Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Monogenetic Disorders Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Monogenetic Disorders Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Celera Group
Abbott
Thermo Fisher Scientific
ELITech Group
Quest
AutoGenomics
PerkinElmer
Roche
Bio-Rad
Transgenomic
Segment by Type
Carrier Testing
Diagnostic Testing
New-Born Screening
Predictive & Pre-Symptomatic Testing
Prenatal Testing
Others
Segment by Application
Hospitals
Specialized Clinics
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Monogenetic Disorders Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monogenetic Disorders Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Carrier Testing
1.2.3 Diagnostic Testing
1.2.4 New-Born Screening
1.2.5 Predictive & Pre-Symptomatic Testing
1.2.6 Prenatal Testing
1.2.7 Others
1.3 Market by Application
1.3.1 Global Monogenetic Disorders Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Specialized Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Monogenetic Disorders Testing Market Perspective (2019-2030)
2.2 Monogenetic Disorders Testing Growth Trends by Region
2.2.1 Global Monogenetic Disorders Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Monogenetic Disorders Testing Historic Market Size by Region (2019-2024)
2.2.3 Monogenetic Disorders Testing Forecasted Market Size by Region (2025-2030)
2.3 Monogenetic Disorders Testing Market Dynamics
2.3.1 Monogenetic Disorders Testing Industry Trends
2.3.2 Monogenetic Disorders Testing Market Drivers
2.3.3 Monogenetic Disorders Testing Market Challenges
2.3.4 Monogenetic Disorders Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Monogenetic Disorders Testing Players by Revenue
3.1.1 Global Top Monogenetic Disorders Testing Players by Revenue (2019-2024)
3.1.2 Global Monogenetic Disorders Testing Revenue Market Share by Players (2019-2024)
3.2 Global Monogenetic Disorders Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Monogenetic Disorders Testing Revenue
3.4 Global Monogenetic Disorders Testing Market Concentration Ratio
3.4.1 Global Monogenetic Disorders Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monogenetic Disorders Testing Revenue in 2023
3.5 Monogenetic Disorders Testing Key Players Head office and Area Served
3.6 Key Players Monogenetic Disorders Testing Product Solution and Service
3.7 Date of Enter into Monogenetic Disorders Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Monogenetic Disorders Testing Breakdown Data by Type
4.1 Global Monogenetic Disorders Testing Historic Market Size by Type (2019-2024)
4.2 Global Monogenetic Disorders Testing Forecasted Market Size by Type (2025-2030)
5 Monogenetic Disorders Testing Breakdown Data by Application
5.1 Global Monogenetic Disorders Testing Historic Market Size by Application (2019-2024)
5.2 Global Monogenetic Disorders Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Monogenetic Disorders Testing Market Size (2019-2030)
6.2 North America Monogenetic Disorders Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Monogenetic Disorders Testing Market Size by Country (2019-2024)
6.4 North America Monogenetic Disorders Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Monogenetic Disorders Testing Market Size (2019-2030)
7.2 Europe Monogenetic Disorders Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Monogenetic Disorders Testing Market Size by Country (2019-2024)
7.4 Europe Monogenetic Disorders Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Monogenetic Disorders Testing Market Size (2019-2030)
8.2 Asia-Pacific Monogenetic Disorders Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Monogenetic Disorders Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Monogenetic Disorders Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Monogenetic Disorders Testing Market Size (2019-2030)
9.2 Latin America Monogenetic Disorders Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Monogenetic Disorders Testing Market Size by Country (2019-2024)
9.4 Latin America Monogenetic Disorders Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Monogenetic Disorders Testing Market Size (2019-2030)
10.2 Middle East & Africa Monogenetic Disorders Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Monogenetic Disorders Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Monogenetic Disorders Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Celera Group
11.1.1 Celera Group Company Detail
11.1.2 Celera Group Business Overview
11.1.3 Celera Group Monogenetic Disorders Testing Introduction
11.1.4 Celera Group Revenue in Monogenetic Disorders Testing Business (2019-2024)
11.1.5 Celera Group Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Monogenetic Disorders Testing Introduction
11.2.4 Abbott Revenue in Monogenetic Disorders Testing Business (2019-2024)
11.2.5 Abbott Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Monogenetic Disorders Testing Introduction
11.3.4 Thermo Fisher Scientific Revenue in Monogenetic Disorders Testing Business (2019-2024)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 ELITech Group
11.4.1 ELITech Group Company Detail
11.4.2 ELITech Group Business Overview
11.4.3 ELITech Group Monogenetic Disorders Testing Introduction
11.4.4 ELITech Group Revenue in Monogenetic Disorders Testing Business (2019-2024)
11.4.5 ELITech Group Recent Development
11.5 Quest
11.5.1 Quest Company Detail
11.5.2 Quest Business Overview
11.5.3 Quest Monogenetic Disorders Testing Introduction
11.5.4 Quest Revenue in Monogenetic Disorders Testing Business (2019-2024)
11.5.5 Quest Recent Development
11.6 AutoGenomics
11.6.1 AutoGenomics Company Detail
11.6.2 AutoGenomics Business Overview
11.6.3 AutoGenomics Monogenetic Disorders Testing Introduction
11.6.4 AutoGenomics Revenue in Monogenetic Disorders Testing Business (2019-2024)
11.6.5 AutoGenomics Recent Development
11.7 PerkinElmer
11.7.1 PerkinElmer Company Detail
11.7.2 PerkinElmer Business Overview
11.7.3 PerkinElmer Monogenetic Disorders Testing Introduction
11.7.4 PerkinElmer Revenue in Monogenetic Disorders Testing Business (2019-2024)
11.7.5 PerkinElmer Recent Development
11.8 Roche
11.8.1 Roche Company Detail
11.8.2 Roche Business Overview
11.8.3 Roche Monogenetic Disorders Testing Introduction
11.8.4 Roche Revenue in Monogenetic Disorders Testing Business (2019-2024)
11.8.5 Roche Recent Development
11.9 Bio-Rad
11.9.1 Bio-Rad Company Detail
11.9.2 Bio-Rad Business Overview
11.9.3 Bio-Rad Monogenetic Disorders Testing Introduction
11.9.4 Bio-Rad Revenue in Monogenetic Disorders Testing Business (2019-2024)
11.9.5 Bio-Rad Recent Development
11.10 Transgenomic
11.10.1 Transgenomic Company Detail
11.10.2 Transgenomic Business Overview
11.10.3 Transgenomic Monogenetic Disorders Testing Introduction
11.10.4 Transgenomic Revenue in Monogenetic Disorders Testing Business (2019-2024)
11.10.5 Transgenomic Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Monogenetic Disorders Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Carrier Testing
Table 3. Key Players of Diagnostic Testing
Table 4. Key Players of New-Born Screening
Table 5. Key Players of Predictive & Pre-Symptomatic Testing
Table 6. Key Players of Prenatal Testing
Table 7. Key Players of Others
Table 8. Global Monogenetic Disorders Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Monogenetic Disorders Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Monogenetic Disorders Testing Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Monogenetic Disorders Testing Market Share by Region (2019-2024)
Table 12. Global Monogenetic Disorders Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Monogenetic Disorders Testing Market Share by Region (2025-2030)
Table 14. Monogenetic Disorders Testing Market Trends
Table 15. Monogenetic Disorders Testing Market Drivers
Table 16. Monogenetic Disorders Testing Market Challenges
Table 17. Monogenetic Disorders Testing Market Restraints
Table 18. Global Monogenetic Disorders Testing Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Monogenetic Disorders Testing Market Share by Players (2019-2024)
Table 20. Global Top Monogenetic Disorders Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monogenetic Disorders Testing as of 2023)
Table 21. Ranking of Global Top Monogenetic Disorders Testing Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Monogenetic Disorders Testing Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Monogenetic Disorders Testing Product Solution and Service
Table 25. Date of Enter into Monogenetic Disorders Testing Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Monogenetic Disorders Testing Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Monogenetic Disorders Testing Revenue Market Share by Type (2019-2024)
Table 29. Global Monogenetic Disorders Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Monogenetic Disorders Testing Revenue Market Share by Type (2025-2030)
Table 31. Global Monogenetic Disorders Testing Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Monogenetic Disorders Testing Revenue Market Share by Application (2019-2024)
Table 33. Global Monogenetic Disorders Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Monogenetic Disorders Testing Revenue Market Share by Application (2025-2030)
Table 35. North America Monogenetic Disorders Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Monogenetic Disorders Testing Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Monogenetic Disorders Testing Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Monogenetic Disorders Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Monogenetic Disorders Testing Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Monogenetic Disorders Testing Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Monogenetic Disorders Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Monogenetic Disorders Testing Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Monogenetic Disorders Testing Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Monogenetic Disorders Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Monogenetic Disorders Testing Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Monogenetic Disorders Testing Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Monogenetic Disorders Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Monogenetic Disorders Testing Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Monogenetic Disorders Testing Market Size by Country (2025-2030) & (US$ Million)
Table 50. Celera Group Company Detail
Table 51. Celera Group Business Overview
Table 52. Celera Group Monogenetic Disorders Testing Product
Table 53. Celera Group Revenue in Monogenetic Disorders Testing Business (2019-2024) & (US$ Million)
Table 54. Celera Group Recent Development
Table 55. Abbott Company Detail
Table 56. Abbott Business Overview
Table 57. Abbott Monogenetic Disorders Testing Product
Table 58. Abbott Revenue in Monogenetic Disorders Testing Business (2019-2024) & (US$ Million)
Table 59. Abbott Recent Development
Table 60. Thermo Fisher Scientific Company Detail
Table 61. Thermo Fisher Scientific Business Overview
Table 62. Thermo Fisher Scientific Monogenetic Disorders Testing Product
Table 63. Thermo Fisher Scientific Revenue in Monogenetic Disorders Testing Business (2019-2024) & (US$ Million)
Table 64. Thermo Fisher Scientific Recent Development
Table 65. ELITech Group Company Detail
Table 66. ELITech Group Business Overview
Table 67. ELITech Group Monogenetic Disorders Testing Product
Table 68. ELITech Group Revenue in Monogenetic Disorders Testing Business (2019-2024) & (US$ Million)
Table 69. ELITech Group Recent Development
Table 70. Quest Company Detail
Table 71. Quest Business Overview
Table 72. Quest Monogenetic Disorders Testing Product
Table 73. Quest Revenue in Monogenetic Disorders Testing Business (2019-2024) & (US$ Million)
Table 74. Quest Recent Development
Table 75. AutoGenomics Company Detail
Table 76. AutoGenomics Business Overview
Table 77. AutoGenomics Monogenetic Disorders Testing Product
Table 78. AutoGenomics Revenue in Monogenetic Disorders Testing Business (2019-2024) & (US$ Million)
Table 79. AutoGenomics Recent Development
Table 80. PerkinElmer Company Detail
Table 81. PerkinElmer Business Overview
Table 82. PerkinElmer Monogenetic Disorders Testing Product
Table 83. PerkinElmer Revenue in Monogenetic Disorders Testing Business (2019-2024) & (US$ Million)
Table 84. PerkinElmer Recent Development
Table 85. Roche Company Detail
Table 86. Roche Business Overview
Table 87. Roche Monogenetic Disorders Testing Product
Table 88. Roche Revenue in Monogenetic Disorders Testing Business (2019-2024) & (US$ Million)
Table 89. Roche Recent Development
Table 90. Bio-Rad Company Detail
Table 91. Bio-Rad Business Overview
Table 92. Bio-Rad Monogenetic Disorders Testing Product
Table 93. Bio-Rad Revenue in Monogenetic Disorders Testing Business (2019-2024) & (US$ Million)
Table 94. Bio-Rad Recent Development
Table 95. Transgenomic Company Detail
Table 96. Transgenomic Business Overview
Table 97. Transgenomic Monogenetic Disorders Testing Product
Table 98. Transgenomic Revenue in Monogenetic Disorders Testing Business (2019-2024) & (US$ Million)
Table 99. Transgenomic Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Monogenetic Disorders Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Monogenetic Disorders Testing Market Share by Type: 2023 VS 2030
Figure 3. Carrier Testing Features
Figure 4. Diagnostic Testing Features
Figure 5. New-Born Screening Features
Figure 6. Predictive & Pre-Symptomatic Testing Features
Figure 7. Prenatal Testing Features
Figure 8. Others Features
Figure 9. Global Monogenetic Disorders Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Monogenetic Disorders Testing Market Share by Application: 2023 VS 2030
Figure 11. Hospitals Case Studies
Figure 12. Specialized Clinics Case Studies
Figure 13. Ambulatory Surgical Centers Case Studies
Figure 14. Monogenetic Disorders Testing Report Years Considered
Figure 15. Global Monogenetic Disorders Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Monogenetic Disorders Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Monogenetic Disorders Testing Market Share by Region: 2023 VS 2030
Figure 18. Global Monogenetic Disorders Testing Market Share by Players in 2023
Figure 19. Global Top Monogenetic Disorders Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monogenetic Disorders Testing as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Monogenetic Disorders Testing Revenue in 2023
Figure 21. North America Monogenetic Disorders Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Monogenetic Disorders Testing Market Share by Country (2019-2030)
Figure 23. United States Monogenetic Disorders Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Monogenetic Disorders Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Monogenetic Disorders Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Monogenetic Disorders Testing Market Share by Country (2019-2030)
Figure 27. Germany Monogenetic Disorders Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Monogenetic Disorders Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Monogenetic Disorders Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Monogenetic Disorders Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Monogenetic Disorders Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Monogenetic Disorders Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Monogenetic Disorders Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Monogenetic Disorders Testing Market Share by Region (2019-2030)
Figure 35. China Monogenetic Disorders Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Monogenetic Disorders Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Monogenetic Disorders Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Monogenetic Disorders Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Monogenetic Disorders Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Monogenetic Disorders Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Monogenetic Disorders Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Monogenetic Disorders Testing Market Share by Country (2019-2030)
Figure 43. Mexico Monogenetic Disorders Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Monogenetic Disorders Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Monogenetic Disorders Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Monogenetic Disorders Testing Market Share by Country (2019-2030)
Figure 47. Turkey Monogenetic Disorders Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Monogenetic Disorders Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Celera Group Revenue Growth Rate in Monogenetic Disorders Testing Business (2019-2024)
Figure 50. Abbott Revenue Growth Rate in Monogenetic Disorders Testing Business (2019-2024)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Monogenetic Disorders Testing Business (2019-2024)
Figure 52. ELITech Group Revenue Growth Rate in Monogenetic Disorders Testing Business (2019-2024)
Figure 53. Quest Revenue Growth Rate in Monogenetic Disorders Testing Business (2019-2024)
Figure 54. AutoGenomics Revenue Growth Rate in Monogenetic Disorders Testing Business (2019-2024)
Figure 55. PerkinElmer Revenue Growth Rate in Monogenetic Disorders Testing Business (2019-2024)
Figure 56. Roche Revenue Growth Rate in Monogenetic Disorders Testing Business (2019-2024)
Figure 57. Bio-Rad Revenue Growth Rate in Monogenetic Disorders Testing Business (2019-2024)
Figure 58. Transgenomic Revenue Growth Rate in Monogenetic Disorders Testing Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
